Literature DB >> 10559527

Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men.

M S van der Gaag1, A van Tol, L M Scheek, R W James, R Urgert, G Schaafsma, H F Hendriks.   

Abstract

Moderate alcohol consumption is associated with a reduced risk of coronary heart disease. Part of this inverse association may be explained by its effects on HDL. Paraoxonase, an HDL-associated enzyme, has been suggested to protect against LDL oxidation. We examined the effects of moderate consumption of red wine, beer and spirits in comparison with mineral water on paraoxonase activity in serum. In this diet-controlled, randomised, cross-over study 11 healthy middle-aged men consumed each of the beverages with evening dinner for 3 weeks. At the end of each 3 week period, blood samples were collected pre- and postprandially and after an overnight fast. Fasting paraoxonase activity was higher after intake of wine (P<0. 001), beer (P<0.001), and spirits (P<0.001) than after water consumption (149.4+/-111.1, 152.6+/-113.1, 152.8+/-116.5 and 143. 1+/-107.9 U/l serum), but did not differ significantly between the 3 alcoholic beverages. Similar effects were observed pre- and postprandially. The increases in paraoxonase activity were strongly correlated with coincident increases in concentrations of HDL-C and apo A-I (r=0.60, P<0.05 and r=0.70, P<0.05). These data suggest that increased serum paraoxonase may be one of the biological mechanisms underlying the reduced coronary heart disease risk in moderate alcohol consumers

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559527     DOI: 10.1016/s0021-9150(99)00243-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  36 in total

1.  The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases.

Authors:  Maharudra Shekhanawar; Sarala M Shekhanawar; D Krisnaswamy; V Indumati; D Satishkumar; V Vijay; T Rajeshwari; M Amareshwar
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 2.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 3.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

4.  No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease.

Authors:  Christine Dalgård; Lene Christiansen; Torbjörn Jonung; Michael I Mackness; Moniek P M de Maat; Mogens Hørder
Journal:  Eur J Nutr       Date:  2007-08-21       Impact factor: 5.614

5.  Is alcohol beneficial or harmful for cardioprotection?

Authors:  Raj Lakshman; Mamatha Garige; Maokai Gong; Leslie Leckey; Ravi Varatharajalu; Samir Zakhari
Journal:  Genes Nutr       Date:  2010-06       Impact factor: 5.523

6.  Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.

Authors:  Eline H van den Berg; Eke G Gruppen; Richard W James; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2018-11-19       Impact factor: 5.922

7.  Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Majken K Jensen; Eric B Rimm
Journal:  Circ J       Date:  2009-05-15       Impact factor: 2.993

8.  Paraoxonase: Its antiatherogenic role in chronic renal failure.

Authors:  M Prakash; N M Phani; R Kavya; M Supriya
Journal:  Indian J Nephrol       Date:  2010-01

9.  A high throughput serum paraoxonase assay for discovery of small molecule modulators of PON1 activity.

Authors:  Tiffany L Graves; John E Scott
Journal:  Curr Chem Genomics       Date:  2008-11-26

10.  High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.

Authors:  Narayani Jayakumari; Gopalan Thejaseebai
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.